Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDGA in Non-Metastatic Recurrent Prostate Cancer
NCT00678015Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- May 2008
- Primary completion
- Feb 2011
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nordihydroguaiaretic acid in prostate cancer (PCa), sponsored by University of California, San Francisco. Started May 2008; status: terminated.
02
Drugs
nordihydroguaiaretic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00678015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678015.